Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$8.71 - $10.72 $4.8 Million - $5.91 Million
-551,478 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$9.2 - $23.86 $714,177 - $1.85 Million
-77,628 Reduced 12.34%
551,478 $5.45 Million
Q4 2020

Feb 02, 2021

BUY
$13.47 - $24.89 $653,874 - $1.21 Million
48,543 Added 8.36%
629,106 $14.5 Million
Q3 2020

Nov 05, 2020

BUY
$12.89 - $15.89 $827,950 - $1.02 Million
64,232 Added 12.44%
580,563 $8.2 Million
Q2 2020

Aug 12, 2020

SELL
$8.86 - $15.69 $46,683 - $82,670
-5,269 Reduced 1.01%
516,331 $7.79 Million
Q1 2020

May 12, 2020

SELL
$6.63 - $11.16 $1.52 Million - $2.55 Million
-228,762 Reduced 30.49%
521,600 $4.82 Million
Q4 2019

Jan 27, 2020

BUY
$7.48 - $10.75 $2.34 Million - $3.36 Million
312,250 Added 71.27%
750,362 $7.31 Million
Q3 2019

Oct 31, 2019

BUY
$8.02 - $13.25 $1.91 Million - $3.15 Million
237,812 Added 118.73%
438,112 $3.51 Million
Q2 2019

Aug 15, 2019

SELL
$10.96 - $14.4 $325,490 - $427,651
-29,698 Reduced 12.91%
200,300 $2.5 Million
Q1 2019

May 03, 2019

SELL
$10.04 - $13.92 $32,127 - $44,544
-3,200 Reduced 1.37%
229,998 $3.13 Million
Q4 2018

Feb 08, 2019

SELL
$8.38 - $13.44 $163,410 - $262,080
-19,500 Reduced 7.72%
233,198 $2.23 Million
Q3 2018

Nov 13, 2018

SELL
$11.6 - $16.54 $183,280 - $261,332
-15,800 Reduced 5.88%
252,698 $3.06 Million
Q2 2018

Aug 15, 2018

BUY
$13.13 - $17.09 $757,955 - $986,554
57,727 Added 27.39%
268,498 $4.19 Million
Q1 2018

May 11, 2018

SELL
$13.76 - $17.12 $231,154 - $287,598
-16,799 Reduced 7.38%
210,771 $3.17 Million
Q4 2017

Feb 06, 2018

BUY
$12.51 - $16.24 $582,590 - $756,296
46,570 Added 25.73%
227,570 $3.28 Million
Q3 2017

Nov 15, 2017

BUY
$11.74 - $15.78 $2.12 Million - $2.86 Million
181,000
181,000 $2.73 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.7B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.